Crohn’s Infusion Treatments: Types, Side Effects & More

If you’ve just been told you may need an infusion for Crohn’s disease, it can feel like a lot. “Infusion” sounds intense, and suddenly you’re picturing IV poles, long clinic visits, and a bag of mystery medicine with your name on it. The good news: infusion treatments are a standard, well-established part of Crohn’s care, and for many people, they’re the reason life starts to feel normal again.

In this guide, we’ll break down the main types of Crohn’s infusion treatments, how they work, what an infusion day is actually like, common side effects, serious risks to know, and practical tips that make the process easier. We’ll also cover the newer pattern many patients see now: an IV “loading” phase followed by at-home injections for maintenance.

Think of this as your no-drama, no-jargon (okay, less jargon) roadmap to infusion therapybecause Crohn’s is complicated enough already.

What Infusion Treatment Means in Crohn’s Disease

Crohn’s disease is a chronic inflammatory bowel disease (IBD), and the main goals of treatment are to reduce inflammation, control symptoms, prevent flares, and help you stay in remission. Medications are central to that plan, and biologics are one of the big categories used when Crohn’s is moderate to severe or not responding well to simpler treatments.

Infusion treatment means the medication is delivered through an IV in a clinic, hospital infusion center, or specialty infusion suite. Some Crohn’s biologics are given only by infusion. Others are given as an IV induction dose (the “starter phase”), then switched to injections for long-term maintenance.

That’s a key point: needing an infusion does not automatically mean you’ll be in a chair every few weeks forever. For several newer medications, infusion is only part of the journey.

When Doctors Usually Consider Infusion Therapy

Infusion biologics are often considered when Crohn’s symptoms are persistent, inflammation is moderate to severe, complications are developing (like fistulas or abscesses), or other medications haven’t worked well enough. They may also be used earlier in the disease course for people at higher risk of complications, depending on your GI specialist’s strategy.

Current U.S. gastroenterology guidance supports several advanced therapies for moderate-to-severe Crohn’s, including infusion-based options and IV-induction biologics. In other words, infusion treatment is not a “last resort”it’s a mainstream, evidence-based treatment path.

Types of Crohn’s Infusion Treatments

1) Anti-TNF Infusions

Example: Infliximab (brand and biosimilars)

Infliximab targets tumor necrosis factor (TNF), a major inflammatory signal in Crohn’s disease. It’s one of the best-known infusion treatments and has been used for years, so clinicians have a lot of experience with it.

Typical schedule: infliximab is usually given at weeks 0, 2, and 6, then every 8 weeks for maintenance. The infusion itself is generally given over at least 2 hours, with monitoring during and after the infusion.

Why it’s common: It can help with moderate-to-severe Crohn’s symptoms and is also frequently used when fistulas are part of the picture. There are also biosimilars, which work like the original biologic and can improve access and cost options.

2) Anti-Integrin Infusions

Examples: Vedolizumab (Entyvio) and Natalizumab (Tysabri)

Vedolizumab is a gut-targeted biologic (an anti-integrin) that blocks inflammatory cells from reaching intestinal tissue. It’s often appealing because of its gut-selective action.

Typical schedule: vedolizumab is commonly given as 300 mg by IV infusion at weeks 0, 2, and 6, then every 8 weeks. The IV infusion is typically about 30 minutes. In some treatment plans, maintenance route options may vary by prescribing information and indication.

Natalizumab is another anti-integrin infusion, but it’s used much less often in Crohn’s because of a serious brain infection risk (PML) and a restricted safety program. It can still be an option in select cases, but it’s usually not the first infusion your GI team reaches for.

Typical schedule: natalizumab is usually 300 mg IV over about 1 hour every 4 weeks.

3) Interleukin Pathway Therapies With IV Induction

Examples: Ustekinumab (Stelara), Risankizumab (Skyrizi), Mirikizumab (Omvoh)

This is the “IV first, injection later” group for many Crohn’s patients.

Ustekinumab (targets IL-12/23 pathways) uses a single weight-based IV induction dose, then moves to 90 mg subcutaneous maintenance starting 8 weeks later and then every 8 weeks.

Risankizumab (targets IL-23) uses 600 mg IV induction at weeks 0, 4, and 8 (infused over at least 1 hour), then transitions to maintenance injections (commonly 180 mg or 360 mg) starting at week 12 and then every 8 weeks.

Mirikizumab (Omvoh) is a newer IL-23 therapy that also uses an IV-to-injection model for Crohn’s. The Crohn’s dosing pattern includes 900 mg IV induction at weeks 0, 4, and 8 (infused over at least 90 minutes), followed by 300 mg subcutaneous maintenance starting at week 12 and then every 4 weeks.

This category is a good example of how “infusion treatment” can be the beginning of a plan rather than the entire long-term routine.

What Happens Before You Start an Infusion

Screening Tests and Safety Checks

Before starting many biologics, your doctor will usually do screening for tuberculosis (TB) and often hepatitis B, especially with anti-TNF therapy such as infliximab. This is a big deal because these medications affect your immune system, and hidden infections can reactivate.

Your team may also check liver tests, blood counts, and other baseline labs depending on the medication. Some drug labels (including newer IL-23 agents) specifically call for liver enzyme and bilirubin checks before treatment and during the induction phase.

Vaccines Matter More Than You Think

Biologics and advanced immune therapies can increase infection risk, so being up to date on vaccines is part of the treatment plannot a random side quest. Crohn’s & Colitis Foundation patient guidance also highlights vaccine discussions (like flu, pneumonia, shingles, and hepatitis vaccines) before or during therapy.

Many infusion medications also warn against live vaccines during treatment. Translation: ask your GI team or pharmacist before getting vaccinated, not after you’re already in the pharmacy line.

What an Infusion Day Is Actually Like

Most infusion visits follow a predictable routine:

• Check-in: you arrive, confirm your medication, and answer a few health questions (fever, infection symptoms, recent antibiotics, etc.).
• Vitals: blood pressure, pulse, and temperature are usually checked.
• IV placement: a nurse starts the IV line.
• Medication infusion: your medicine runs over a set time (anywhere from ~30 minutes to 2+ hours depending on the drug).
• Monitoring: staff watch for infusion reactions during and sometimes after treatment.

For infliximab in particular, the prescribing information notes monitoring during infusion and after completion. Some people also get premedications (like acetaminophen or an antihistamine) if their doctor wants to reduce the chance of an infusion reaction.

Pro tip: bring a hoodie, headphones, and something to do. The infusion center is basically the one place where “I’m unavailable for an hour because I’m getting medicine” is a completely valid reason to ignore your notifications.

Common Side Effects of Crohn’s Infusion Treatments

Side effects depend on the medication, but there’s a lot of overlap across biologics and infusion therapies.

Common Infusion-Related or Mild-to-Moderate Side Effects

• Headache
• Fatigue
• Nausea
• Fever or chills
• Rash or hives
• Itching or redness (including at injection sites for medications that later switch to shots)
• Joint aches (arthralgia)
• Upper respiratory infections (like colds or sinus symptoms)

Crohn’s & Colitis Foundation patient materials and multiple drug labels describe these as common patterns. Some medications have their own “signature” side effectsfor example, infliximab commonly lists infusion reactions, headache, and abdominal pain; vedolizumab commonly lists headache, joint pain, nausea, and respiratory symptoms; and IL-23 therapies often list upper respiratory symptoms, headache, joint pain, or injection-site reactions during maintenance phases.

Infusion Reactions

Infusion reactions can happen during the infusion or shortly afterward. They can include flushing, itching, rash, headache, shortness of breath, chest discomfort, or dizziness. Most are manageable, but severe reactions can happen, and nurses are trained to stop the infusion and treat symptoms if needed.

Important: delayed reactions can also occur (for example, later the same day or in the days after treatment), so your team will tell you what to watch for and when to call.

Serious Risks You Should Know (Without Panic-Googling)

This section isn’t here to scare you. It’s here so you know what your care team is screening for and why they ask so many questions before each infusion.

1) Serious Infections

Most biologics can increase infection risk. Some labels specifically warn about serious infections requiring hospitalization, including TB and other opportunistic infections. This is one reason your team asks about fever, cough, urinary symptoms, or recent infections before each visit.

2) TB and Hepatitis B Reactivation

This is especially emphasized with anti-TNF drugs like infliximab. Screening before treatment is standard practice. If you’ve ever had TB exposure or hepatitis B in the past, tell your GI team early so they can plan safely.

3) Liver Problems

Some infusion and IV-induction therapies include liver warnings and recommend periodic lab monitoring. If you notice yellowing of the skin/eyes, dark urine, or severe fatigue, call your clinician promptly.

4) Rare Neurologic Risks (Especially Natalizumab)

Natalizumab carries a boxed warning for progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. It’s also only available through a restricted safety program (TOUCH). That’s a major reason natalizumab is used selectively in Crohn’s care.

5) Allergic or Hypersensitivity Reactions

Severe allergic reactions (including anaphylaxis) are uncommon but possible with several biologics. That’s why infusions happen in a monitored medical setting.

6) Malignancy and Other Rare Risks

Crohn’s & Colitis Foundation and anti-TNF labeling both discuss rare risks, including certain cancers (such as lymphoma risk, especially in some combination-therapy situations), skin cancer risk, and other uncommon immune-related side effects. These risks are part of the risk-benefit conversation your doctor will personalize for you.

How Doctors Choose the “Right” Infusion

There isn’t one best infusion for everyone with Crohn’s. Your GI specialist will usually weigh:

• How severe your disease is (and whether you have fistulas, strictures, abscess history, etc.)
• Where your Crohn’s is located in the digestive tract
• Your past medication history (what worked, what didn’t, what caused side effects)
• Other health conditions (including infection history, liver issues, neurologic history, pregnancy planning)
• Lifestyle and logistics (infusion center access, work/school schedule, comfort with injections)
• Insurance coverage and biosimilar availability

For example, someone who prefers fewer clinic visits after the initial phase may do well with an IV-induction-then-injection option. Someone else may prefer ongoing infusion-center support because they don’t want to self-inject. Both are valid.

When Infusions Don’t Work Well Enough

Sometimes an infusion works great at first and then seems to fade. Sometimes it never quite gets you into remission. This does not mean you failed treatment. It usually means your doctor needs to adjust the plan.

Common next steps include:

• Changing the dose or interval (for certain medications)
• Checking drug levels/antibodies (when appropriate)
• Adding another medication for combination therapy
• Switching to a different biologic class
• Reassessing for complications that may need surgery

Mayo Clinic and other specialty centers also emphasize that surgery may still be needed in Crohn’s disease, especially when symptoms don’t respond to medication or complications develop. Surgery can be very helpful, but it doesn’t “cure” Crohn’s, so medical therapy often remains part of the long-term plan.

Practical Tips for Managing Infusion Side Effects

Before Your Visit

• Hydrate well the day before and the day of the infusion (your veins will thank you).
• Eat a light meal unless your clinic tells you otherwise.
• Bring a current medication list and mention any recent infections.
• Ask your doctor what symptoms should delay an infusion (fever, antibiotics, etc.).

During the Visit

• Tell the nurse immediately if you feel flushed, itchy, short of breath, dizzy, or “off.”
• Bring layersinfusion centers can be either “cozy” or “why is it 61°F in here?”
• Use the time: podcasts, a nap, schoolwork, spreadsheets, existential reflection… your call.

After the Visit

• Track how you feel for 24–48 hours (fatigue, headache, rash, symptoms improving, etc.).
• Call your care team for fever, severe rash, breathing issues, worsening pain, or infection symptoms.
• Keep your infusion schedule consistenttiming matters with biologics.

Real-World Experiences and Lessons From the Infusion Chair

The following are composite patient-style experiences based on common patterns people describe in GI clinics and support communitiesnot individual medical stories.

Experience 1: “The first infusion was scarier than the infusion itself.”
A lot of people say the anxiety before the first visit is the worst part. One common story: a patient spends three days imagining worst-case scenarios, then shows up and discovers the infusion center is basically a quiet room with recliners, warm blankets, and nurses who have seen everything. The IV start is the main “ouch” moment, and the rest is mostly waiting. This matters because fear can make people delay treatment. Once they know what the process feels like, the second visit is usually much easier.

Experience 2: “I didn’t feel better instantlyand that didn’t mean it wasn’t working.”
Another common experience is expecting dramatic overnight improvement. Sometimes that happens, but often symptom relief is gradual. Anti-TNF and other biologics can take time, especially in the induction phase. Patients often describe small wins first: less urgency, fewer bathroom trips, better energy, or less cramping. The emotional lesson here is huge: progress in Crohn’s is often a slow climb, not a movie montage.

Experience 3: “My doctor switched me, and it was actually the right move.”
It’s very common for Crohn’s treatment plans to evolve. A patient may do well on one infusion for a while, then symptoms creep back. In real-life practice, that can lead to dose changes, interval adjustments, or switching to another class (for example, from anti-TNF to an IL-23 pathway therapy). Patients sometimes see a treatment switch as “bad news,” but experienced GI teams see it as normal disease management. Crohn’s care is often about finding the right match, not just the first match.

Experience 4: “Side effects were manageable once I knew the pattern.”
Some people feel tired after infusions. Others get mild headaches, feel a little flu-ish, or notice a rash/itching episode that the nurse manages quickly. A pattern people describe is that side effects become less stressful once they know what’s normal for their body. Many keep a simple note in their phone: infusion date, how they felt that night, how they felt the next day, and when symptoms improved. That log can be surprisingly helpful at follow-up visits.

Experience 5: “Planning around treatment made life feel normal again.”
Patients who do best long-term often build routines around infusions instead of fighting them. They schedule visits on low-demand days, pack snacks, wear easy sleeves, and treat infusion day as protected time. Some use it as a monthly reset. Parents arrange childcare. Students bring assignments. People with busy jobs block the calendar. It sounds simple, but turning infusion therapy from a disruption into a routine can reduce stress a lot.

Experience 6: “The support piece mattered as much as the medication.”
Crohn’s treatment is physical, but it’s also mental. People often describe feeling isolated until they talk with a GI nurse, a support group, or another patient who’s been through infusions. Even practical reassurancelike “yes, it’s normal to be tired after the first one” or “bring a sweater”can make a difference. Medication controls inflammation, but support helps people stay consistent with treatment, ask better questions, and feel less overwhelmed.

The takeaway from these real-world patterns: infusion therapy is rarely just about the drug. It’s also about timing, expectations, follow-up, and building a routine that works in real life. When those pieces come together, infusion treatment can become something far less intimidatingand much more effective.

Conclusion

Crohn’s infusion treatments include several proven options, from long-standing anti-TNF therapy (like infliximab) to gut-targeted anti-integrin treatment (like vedolizumab) and newer IV-induction biologics in the interleukin pathway (like ustekinumab, risankizumab, and mirikizumab). Each has its own dosing schedule, side-effect profile, and safety monitoring needs.

The best treatment choice depends on your disease pattern, medical history, goals, and day-to-day lifenot just the name of the drug. The good news is that Crohn’s treatment options are broader than ever, and your GI team can adjust the plan if the first one isn’t the perfect fit.

If you’re starting infusions soon, bring your questions, bring a charger, and bring your “I can do this” attitude. The chair is not the fun partbut feeling better might be.